Related Experiment Video
Updated: Jul 29, 2025

Facilitating the Analysis of Immunological Data with Visual Analytic Techniques
Published on: January 2, 2011
Data visualization explorer: A tool for participant representation in pivotal trials of FDA-approved medicinal
Ariel B Carmeli1,2, Laura Meloney3, Barbara E Bierer3,4
1Department of Biomedical Informatics, Harvard Medical School, Boston, MA 02115 USA.
Abstract:
This paper presents a 2015-2021 US Food and Drug Administration (FDA) Drug Trials Snapshots (DTS) Data Visualization Explorer-an interactive data visualization web-based tool (https://arielcarmeli.shinyapps.io/fda-drug-trial-snapshots-data-explorer) built in R and based on publicly available FDA clinical trial participation data and disease incidence data from the National Cancer Institute and Centers for Disease Control and Prevention. FDA data can be explored by race, ethnicity, sex, age group, therapeutic area, pharmaceutical sponsor, and approval year for clinical trials that supported each of the 339 FDA drug and biologic approvals between 2015 and 2021. This work provides several advantages relative to past literature and DTS reports: a dynamic data visualization tool; race, ethnicity, sex, and age group data presented in one place; data on sponsor; and emphasis on data distributions instead of averages. We present recommendations for improved data access, reporting, and communication to assist leaders in making evidence-based decisions to improve trial representation to enhance health equity.
Related Concept Videos
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Analysis of Population Pharmacokinetic Data
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Drug Discovery: Overview
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

